Skip to main content

Table 3 Demographics and clinical data for HIV patients diagnosed with active TB

From: HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study

Origin

Age

Gender

Years in Norway

Previous TB (years)

Symptoms

CD4 count

HIV RNA (copies/ml)

TST (mm)

QFT (IU/ml)

TSPOT

Culture/PCR positive

Chest x-ray pathology

TB localization

Resistance

South-east Asia

40

F

6

n/a

Yes

302

<20

nd

2.66

nd

+/+

-

Pulmonary

-

East-africa

45

M

6

n/a

Yes

340

8750

10

10

+

+/+

-

Abdominal

-

Central-africa

33

F

5

1

Yes

190

70

nd

10

nd

+/+

-

Lymph node

MDR

Central-africa

43

M

3

2

No

480

<20

0

0.62

b.l

-/nd

+

Pulmonary

n/a

East-africa

42

F

1

1

No

50

>100000

0

0.34

+

-/nd

+

Pulmonary

n/a

East-africa

50

M

1

11

No

50

>100000

0

0.81

-

+/nd

-

Pulmonary

-

West-africa

38

M

7

n/a

No

270

>100000

nd

10

+

+/+

+

Pulmonary

INH

  1. n/a = noe applicable, nd = not done, b.l = borderline, MDR = multi drug-resistant TB, INH – isoniazide.